Page 5 - Read Online

9 Lycopene treatment stalls the onset of experimentally induced hepatocellular carcinoma: a
radioisotopic, physiological and biochemical analysis
Nisha Bhatia, Baljinder Singh, Ashwani Koul
Hepatoma Res 2018;4:9 http://dx.doi.org/10.20517/2394-5079.2018.04

10 Systemic therapies for hepatocellular carcinoma: a recap of the current status
Petros Giovanis, Manuela De Bona, Fabio Farinati, Andrea Buda, Riccardo Berletti, Fable Zustovich,
Simona D’Ippolito, Michele De Boni, Umberto Cillo, Davide Pastorelli
Hepatoma Res 2018;4:10 http://dx.doi.org/10.20517/2394-5079.2018.21

11 A potential clinical based score in hepatitis C virus cirrhotic patients to exclude small
hepatocellular carcinoma
Denise Cerqueira Paranaguá-Vezozzo, Celso Eduardo Lourenço Matielo, Daniel Ferraz de Campos
Mazo, Lucas Souto Nacif, Mario Guimaraes Pessoa, Gleicy Luz Reinoso Pereira, Roque Gabriel
Rezende de Lima, Patricia Momoyo Yoshimura Zitelli, Suzane Kioko Ono, Flair José Carrilho
Hepatoma Res 2018;4:11 http://dx.doi.org/10.20517/2394-5079.2018.17

12 BetaI cooperate with hepatitis B surface antigen promotes hepatocellular carcinogenesis via the
nuclear factor kappa B signal pathway were enhanced by the lipopolysaccharide
Xue-Li Ding, Xue Jing, Nai-Jun Han, Zi-Bin Tian, Pu-Jun Gao, Lin Yang, Ya-Nan Yu
Hepatoma Res 2018;4:12 http://dx.doi.org/10.20517/2394-5079.2018.07

13 Neoadjuvant hepatic arterial infusion chemotherapy for resectable hepatocellular carcinomas
Rina Tsutsui, Hiroaki Nagamatsu, Osamu Itano, Akihiro Deguchi, Tsubasa Tsutsumi, Mamoru Hiraki,
Naohisa Mizukami, Jun Akiba
Hepatoma Res 2018;4:13 http://dx.doi.org/10.20517/2394-5079.2018.20

14 New strategy to distinguish clonal origin of RHCC/MHCC between intrahepatic metastasis and
multicentric occurrence
Han Wang, Wen-Ming Cong
Hepatoma Res 2018;4:14 http://dx.doi.org/10.20517/2394-5079.2018.16

15 Hepatocellular carcinoma in patients without cirrhosis: relevance and clinical characteristics
Kellyane Santana Dias Carvalho, Luciano E. Fonseca, Helma P. Cotrim
Hepatoma Res 2018;4:15 http://dx.doi.org/10.20517/2394-5079.2018.13

16 T cell immunotherapy in hepatitis B virus related hepatocellular carcinoma
Morteza Hafezi, Antonio Bertoletti, Anthony T. Tan
Hepatoma Res 2018;4:16 http://dx.doi.org/10.20517/2394-5079.2018.55

17 Pre-S2 and HBV associated hepatocellular carcinoma
Ying Zheng, Yan-Yan Qian, Hong Fan
Hepatoma Res 2018;4:17 http://dx.doi.org/10.20517/2394-5079.2018.08